Glutamina Peptide: Glutamine Chemistry Inside a Chain

By What Peptides Editorial Team · Updated 2026-09-14 · Part of Peptide Structure, Classification & Scientific Terminology

Glutamina is glutamine in Spanish, Italian and Portuguese, and the search term glutamina peptide is best read as a truncated or translated form of glutamine peptide. No distinct molecule called glutamina peptide appears in the standard chemical or protein databases, so this page does not describe one. What can be described accurately is the chemistry of glutamine as a residue inside a chain, which is what the term most plausibly points at and is substantial in its own right. Glutamine is one of the twenty common residues and is the amide of glutamic acid: a three-carbon side chain ending in a carboxamide.

That single functional group drives most of what is interesting about the residue. It is polar and uncharged at ordinary pH, it donates and accepts hydrogen bonds, it supplies amide nitrogen in several biosynthetic reactions, and it is chemically labile in ways that matter to anyone measuring a peptide by mass. Two modifications in particular, deamidation and pyroglutamate formation, are common enough to be expected rather than exceptional. The notation used below follows the conventions in peptide structure and classification terminology, and the analytical consequences are followed up in how peptides are identified from a digest.

The amide side chain and what it does

Glutamine carries a side chain of CH2-CH2-CO-NH2. As a free amino acid it has a monoisotopic mass of 128.0586 Da; as a residue in a chain, after the 18.0106 Da of water lost in forming the peptide bonds, it contributes about 110 Da, which is why that figure is the usual rule of thumb for an average residue. The carboxamide is uncharged across the physiological pH range and can both donate and accept hydrogen bonds, so glutamine is common on protein surfaces, in polar interfaces between chains, and in the hydrogen-bond networks that hold folded cores together.

Glycosylation is where the amide-bearing residue is most often discussed, and precision matters here. N-linked glycosylation occurs on asparagine within the sequon Asn-X-Ser or Asn-X-Thr, where X is not proline; glutamine cannot stand in at that position, and replacing the asparagine with glutamine is the standard control experiment that abolishes glycosylation at a given site. O-linked glycosylation is conventionally on serine and threonine, with tyrosine, hydroxylysine and hydroxyproline also documented, so a glutamine residue is not itself an O-glycosylation site. What glutamine does contribute is a competing reaction of its own: deamidation, which adds 0.984 Da and must be distinguished from a genuine modification during analysis.

One further reaction is worth knowing because it appears in food chemistry and in biomaterials. Transglutaminases form an isopeptide bond between the carboxamide of a glutamine side chain and the amino group of a lysine side chain, releasing ammonia and crosslinking two chains covalently.

Deamidation, pyroglutamate and the mass shifts analysts look for

Deamidation converts glutamine to glutamic acid with loss of ammonia, a change of +0.98402 Da. It is accelerated by heat and by alkaline pH, and it proceeds through a cyclic imide intermediate. Glutamine deamidates far more slowly than asparagine, and the usual explanation is geometric: asparagine forms a five-membered succinimide ring readily, while glutamine would have to form a six-membered glutarimide, which is much less favorable. The analytical consequence is a mass increase of just under one dalton, which is close to the one-dalton spacing that readers use to interpret isotope patterns, so distinguishing a deamidation artifact from a real modification needs resolving power typically above 50,000, plus chromatographic separation, because the acid and amide forms also differ in retention.

Pyroglutamate formation is the second predictable modification. An N-terminal glutamine can cyclize, with the side-chain amide nitrogen attacking the alpha-carbonyl to form a five-membered ring and expelling ammonia, a loss of 17.0265 Da that gives pyroglutamate, also called 5-oxoproline. An N-terminal glutamic acid can reach the same product by losing water instead, 18.0106 Da. Either way the product has no free alpha-amino group, so Edman degradation stops at the first cycle, which is the classical meaning of a blocked N-terminus. The modification is common in antibodies and in several peptide hormones, and it is one of the first explanations to test when a measured N-terminal mass does not match the predicted one.

Neither modification is only a nuisance. Deamidation changes the charge of a residue at neutral pH, which shifts electrophoretic and chromatographic behavior even when the mass change looks trivial, and it introduces heterogeneity into a preparation that was designed to be one molecule. Pyroglutamate removes a charge and makes a chain more resistant to aminopeptidases. Both can arise during storage rather than during synthesis, so a stability study separates what was made from what happened afterwards, and sample preparation is adjusted accordingly: near-neutral pH, low temperature, and minimal time in solution before analysis.

Why glutamine-rich sequences aggregate

Runs of glutamine are the best-known aggregation-prone sequence in human genetics. CAG repeats encode glutamine tracts, and expansion of those repeats within coding sequence is the cause of several inherited neurodegenerations: huntington disease in the HTT gene, several spinocerebellar ataxias, dentatorubral-pallidoluysian atrophy, and Kennedy disease in the androgen receptor. Reported threshold lengths differ by gene, with a commonly cited figure of about 35 to 40 glutamines for HTT, and longer repeats are reported in the literature to correlate with earlier onset. These are associations reported in the clinical genetics literature, not statements about any product, and this page draws no conclusion from them beyond the chemistry.

The structural explanation most often invoked is the polar zipper: glutamine side-chain amides hydrogen-bond to each other and to the peptide backbone, so a polyglutamine tract can form a beta-sheet-like structure with amide ladders running along the sheet edge, and those sheets assemble into amyloid-like fibrils in vitro. Glutamine-rich, low-complexity regions are not pathological in themselves; they occur in many transcription factors and RNA-binding proteins, where they mediate weak, multivalent interactions and the formation of condensates. For a chemist, the practical notes are simple: polyglutamine tracts are poorly soluble, prone to aggregation in solution, difficult to synthesize and purify, and they behave badly on size exclusion columns, where they can elute earlier than their mass predicts.

This page is part of the Peptide Structure, Classification & Scientific Terminology guide.